AYURF (Ayurcann Holdings) E10: $-0.02 (As of Sep. 2025)


What is Ayurcann Holdings E10?

Ayurcann Holdings AYURF E10 is $-0.02 as of Sep. 2025. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ayurcann Holdings's adjusted earnings per share data for the three months ended in Sep. 2025 was $-0.007. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.02 for the trailing ten years ended in Sep. 2025.

During the past 3 years, the average E10 Growth Rate was 30.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Ayurcann Holdings was 30.70% per year. The lowest was 14.00% per year. And the median was 22.35% per year.

As of today (2026-07-05), Ayurcann Holdings's current stock price is $0.0021. Ayurcann Holdings's E10 for the quarter that ended in Sep. 2025 was $-0.02. Ayurcann Holdings's Shiller PE Ratio of today is .


Ayurcann Holdings  (OTCPK:AYURF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ayurcann Holdings E10 Related Terms


Ayurcann Holdings E10 Historical Data

* Premium members only.

The historical data trend for Ayurcann Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ayurcann Holdings E10 Chart

Ayurcann Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Jun21 Jun22 Jun23 Jun24 Jun25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.07 -0.07 -0.05 -0.02

Ayurcann Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.02 -0.02 -0.02 -0.02

AYURF vs BSPK, SKYI, CPMD: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ayurcann Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ayurcann Holdings Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ayurcann Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ayurcann Holdings's Shiller PE Ratio falls into.



Ayurcann Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ayurcann Holdings's adjusted earnings per share data for the three months ended in Sep. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2025 (Change)*Current CPI (Sep. 2025)
=-0.007/130.2900*130.2900
=-0.007

Current CPI (Sep. 2025) = 130.2900.

Ayurcann Holdings Quarterly Data

per share eps CPI Adj_EPS
201512 -0.003 99.947 -0.004
201603 -0.003 101.054 -0.004
201606 -0.003 102.002 -0.004
201609 -0.021 101.765 -0.027
201612 -0.003 101.449 -0.004
201703 -0.003 102.634 -0.004
201706 -0.004 103.029 -0.005
201709 -0.006 103.345 -0.008
201712 -0.004 103.345 -0.005
201803 -0.003 105.004 -0.004
201806 -0.002 105.557 -0.002
201809 0.000 105.636 0.000
201812 -0.004 105.399 -0.005
201903 -0.002 106.979 -0.002
201906 -0.002 107.690 -0.002
201909 -0.007 107.611 -0.008
201912 -0.004 107.769 -0.005
202003 -0.003 107.927 -0.004
202006 -0.002 108.401 -0.002
202009 0.000 108.164 0.000
202012 -0.002 108.559 -0.002
202103 -0.011 110.298 -0.013
202106 0.011 111.720 0.013
202109 0.001 112.905 0.001
202112 -0.001 113.774 -0.001
202203 -0.004 117.646 -0.004
202206 -0.016 120.806 -0.017
202209 -0.005 120.648 -0.005
202212 -0.001 120.964 -0.001
202303 -0.005 122.702 -0.005
202306 -0.011 124.203 -0.012
202309 -0.001 125.230 -0.001
202312 -0.004 125.072 -0.004
202403 -0.001 126.258 -0.001
202406 -0.009 127.522 -0.009
202409 0.000 127.285 0.000
202412 -0.001 127.364 -0.001
202503 -0.002 129.181 -0.002
202506 -0.011 129.892 -0.011
202509 -0.007 130.290 -0.007

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.02 mean?
Ayurcann Holdings (AYURF) has a E10 of $-0.02 as of Sep. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ayurcann Holdings and its competitors.
Is Ayurcann Holdings' E10 too high?
Ayurcann Holdings' current E10 is $-0.02.
How does Ayurcann Holdings' E10 compare to BSPK and SKYI?
Ayurcann Holdings' E10 of $-0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ayurcann Holdings and its competitors. Ayurcann Holdings's current E10 is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ayurcann Holdings stock overvalued right now?
Ayurcann Holdings (AYURF) has a current E10 of $-0.02. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 79% below its estimated fair value. The current E10 is $-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Ayurcann Holdings (AYURF), the current E10 is $-0.02 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ayurcann Holdings Business Description

Address 1080 Brock Road, Unit 6, Pickering, ON, CAN, L1W 3H3
Ayurcann Holdings Corp is engaged in providing post-harvest outsourcing solutions to licensed cannabis producers and the manufacture and distribution of cannabis products.